Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study-Reference-Cited by-同舟云学术

Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study

Published:2009-01-13 Issue:1 Volume:9 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Gandemer Virginie, ,Auclerc Marie-Francoise,Perel Yves,Vannier Jean-Pierre,Le Gall Edouard,Demeocq Francois,Schmitt Claudine,Piguet Christophe,Stephan Jean-Louis,Lejars Odile,Debre Marianne,Jonveaux Philippe,Cayuela Jean-Michel,Chevret Sylvie,Leverger Guy,Baruchel Andre

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/article/10.1186/1471-2407-9-14/fulltext.html

Reference22 articles.

1. Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig W-D, Henze G, Gadner H, Odenwald E, Riehm H: Long term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia. 2000, 14: 2205-2222. 10.1038/sj.leu.2401973.

2. Roy A, Bradburn M, Moorman A, Burrett J, et al: Early response to induction is predictive of survival in chilhood philadelphia chromosome positive acute lymphoblastic leukemia: results of the Medical Research Council ALL 97 trial. Br J Haematol. 2005, 129: 35-44. 10.1111/j.1365-2141.2005.05425.x.

3. Schultz K, Pullen D, Sather H, Shuster J, Devidas M, Borowitz M, Carroll A, Heerema N, Rubnitz J, Loh M, Raetz E, Winick N, Hunger S, Carroll W, Gaynon P, Camitta B: Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood. 2007, 109: 926-935. 10.1182/blood-2006-01-024729.

4. Arico M, Valsecchi M, Camitta B, Schrappe M, Chessells J, Baruchel A, Gaynon P, Silverman L, Janka-Schaub G, Kamps W, Pui C-H, Masera G: Outcome of treatment in children with philadelphia chromosome positive childhood acute lymphoblastic leukemia. N Engl J Med. 2000, 342: 998-1006. 10.1056/NEJM200004063421402.

5. Oudot C, Auclerc MF, Levy M, Porcher R, Piguet C, Perel Y, Gandemer V, Debre M, Vermylen C, Pautard B, Berger C, Schmitt C, Leblanc T, Cayuela JM, Socie G, Michel G, Leverger G, Baruchel A: Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study. J Clin Oncol. 2008, 26 (9): 1496-1503. 10.1200/JCO.2007.12.2820.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study;Journal of Clinical Oncology;2023-03-01

2. Therapeutic approach and outcome of children with Philadelphia chromosome‐positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors: An SFCE retrospective study;Pediatric Blood & Cancer;2021-12-02

3. Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era;Biology of Blood and Marrow Transplantation;2019-08

4. Outcome and prognostic factors of children with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib followed by allogeneic hematopoietic cell transplantation in first remission;BLOOD RESEARCH;2019-03-31

5. Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center;Archives of Pathology & Laboratory Medicine;2016-02-23